Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

E.H. Tan, K. Khoo, Joseph Wee, +11

Annals of Oncology

Carboplatin CombinationPhase Ii TrialMedicineMetronomic TherapyPathology +5

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

Wan‐Teck Lim, E.H. Tan, Chee‐Keong Toh, +5

Annals of Oncology

Solid TumorsMedicinePharmacologyPharmacotherapyAnti-cancer Agent +3

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Whay Kuang Chia, W.-W. Wang, Melissa Ching Ching Teo, +7

Annals of Oncology

Vaccine SafetyTumor ImmunologyVaccine DevelopmentMedicineImmunology +8

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Kian Fong Foo, E.H. Tan, Swan Swan Leong, +7

Annals of Oncology

MedicineNasopharyngeal CancerPathologyMetastatic Nasopharyngeal CarcinomaOncology +2

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

C. Manegold, Nico van Zandwijk, A. Szczęsna, +12

Annals of Oncology

OncologyTlr9 AgonistMedicinePhase IiiMetronomic Therapy +6

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Joanne Ngeow, Wan‐Teck Lim, Swan Swan Leong, +5

Annals of Oncology

OncologyDisseminated Nasopharyngeal CarcinomaMetronomic TherapyNasopharyngeal CancerPathology +3

Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney

Yanjuan Hou, E.H. Tan, Honghong Shi, +9

Cellular and Molecular Life Sciences

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

E.H. Tan, Janusz Rolski, Tomasz Grodzki, +8

Annals of Oncology

Final ResultsCisplatin Versus DocetaxelMedicineBronchial NeoplasmFirst-line Treatment +6

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

P.-J. Souquet, E.H. Tan, José Rodrigues Pereira, +6

Annals of Oncology

MedicineMetronomic TherapyBronchial NeoplasmCancer TreatmentOncology +4

Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer

E. Au, E.H. Tan, P T Ang

Annals of Oncology

OncologyMedicineImmune Checkpoint InhibitorPharmacotherapyCancer Treatment +3